SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eli Lilly
LLY 1,071+1.3%Dec 19 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (370)10/21/1998 9:32:00 PM
From: Anthony Wong   of 642
 
10/21 11:14 Danish shares fall on profit-taking, Novo<NVOb.CO>

COPENHAGEN, Oct 21 (Reuters) - Danish shares fell on Wednesday in thin
trade marked by profit-taking, and with bio-tech blue-chip Novo Nordisk
dented by a sales advance of rival Eli Lilly<LLY.N> in Novo's main markets,
dealers said.

The KFX top-20 index shed 1.50 points or 0.75 percent to 197.18 in modest
520 million crown turnover. The KFX November future fell 3.00 points to
198.00.

Novo Nordisk fell 18 crowns to 700. Eli Lilly posted 19 percent higher Q3
sales with insulin sales outside the United States up 18 percent. This was bad
news for Novo as it implied that the Danish company had lost market share,
dealers said.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext